269 related articles for article (PubMed ID: 24744756)
1. Effects of Peptide on NK cell-mediated MHC I recognition.
Cassidy SA; Cheent KS; Khakoo SI
Front Immunol; 2014; 5():133. PubMed ID: 24744756
[TBL] [Abstract][Full Text] [Related]
2. NK cells: tuned by peptide?
Das J; Khakoo SI
Immunol Rev; 2015 Sep; 267(1):214-27. PubMed ID: 26284480
[TBL] [Abstract][Full Text] [Related]
3. Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.
Cheent KS; Jamil KM; Cassidy S; Liu M; Mbiribindi B; Mulder A; Claas FH; Purbhoo MA; Khakoo SI
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16981-6. PubMed ID: 24082146
[TBL] [Abstract][Full Text] [Related]
4. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal age related change in natural killer cell receptors for MHC class I.
Lutz CT; Moore MB; Bradley S; Shelton BJ; Lutgendorf SK
Mech Ageing Dev; 2005; 126(6-7):722-31. PubMed ID: 15888327
[TBL] [Abstract][Full Text] [Related]
6. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
7. A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
Davis ZB; Cogswell A; Scott H; Mertsching A; Boucau J; Wambua D; Le Gall S; Planelles V; Campbell KS; Barker E
PLoS Pathog; 2016 Feb; 12(2):e1005421. PubMed ID: 26828202
[TBL] [Abstract][Full Text] [Related]
8. Two to Tango: Co-evolution of Hominid Natural Killer Cell Receptors and MHC.
Wroblewski EE; Parham P; Guethlein LA
Front Immunol; 2019; 10():177. PubMed ID: 30837985
[TBL] [Abstract][Full Text] [Related]
9. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
Lin Chua H; Brahmi Z
Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
[TBL] [Abstract][Full Text] [Related]
10. Structure of the murine CD94-NKG2A receptor in complex with Qa-1
MacLachlan BJ; Sullivan LC; Brooks AG; Rossjohn J; Vivian JP
FEBS J; 2024 Apr; 291(7):1530-1544. PubMed ID: 38158698
[TBL] [Abstract][Full Text] [Related]
11. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
12. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
[TBL] [Abstract][Full Text] [Related]
13. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
[TBL] [Abstract][Full Text] [Related]
14. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
[TBL] [Abstract][Full Text] [Related]
15. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.
Yu J; Venstrom JM; Liu XR; Pring J; Hasan RS; O'Reilly RJ; Hsu KC
Blood; 2009 Apr; 113(16):3875-84. PubMed ID: 19179302
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
[TBL] [Abstract][Full Text] [Related]
17. Taking license with natural killer cell maturation and repertoire development.
Parham P
Immunol Rev; 2006 Dec; 214():155-60. PubMed ID: 17100883
[TBL] [Abstract][Full Text] [Related]
18. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
19. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.
Lee N; Llano M; Carretero M; Ishitani A; Navarro F; López-Botet M; Geraghty DE
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5199-204. PubMed ID: 9560253
[TBL] [Abstract][Full Text] [Related]
20. What a Difference an Amino Acid Makes: An All-Atom Simulation Study of Nonameric Peptides in Inhibitory HLA-E/NKG2A/CD94 Immune Complexes.
Prašnikar E; Perdih A; Borišek J
Front Pharmacol; 2022; 13():925427. PubMed ID: 35991867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]